-
1
-
-
10644275213
-
Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine-Resistant Hepatitis B Virus Infection
-
van Bommel F, Wünsche T, Mauss S, Reinke P, Bergk A, Schürmann D, et al. Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine-Resistant Hepatitis B Virus Infection. HEPATOLOGY 2004;40:1421-1425.
-
(2004)
Hepatology
, vol.40
, pp. 1421-1425
-
-
Van Bommel, F.1
Wünsche, T.2
Mauss, S.3
Reinke, P.4
Bergk, A.5
Schürmann, D.6
-
2
-
-
3042811705
-
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir
-
Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir. Antivir Ther 2004;9:353-363.
-
(2004)
Antivir Ther
, vol.9
, pp. 353-363
-
-
Lada, O.1
Benhamou, Y.2
Cahour, A.3
Katlama, C.4
Poynard, T.5
Thibault, V.6
-
3
-
-
0034108712
-
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir
-
Ying C, De Clercq E, Nicholson W, Furman P, Neyts J. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir. J Viral Hepat 2000;7:161-165.
-
(2000)
J Viral Hepat
, vol.7
, pp. 161-165
-
-
Ying, C.1
De Clercq, E.2
Nicholson, W.3
Furman, P.4
Neyts, J.5
-
4
-
-
20944434590
-
In vitro characterisation of anti-HBV efficacy and intracellular metabolism of tenofovir
-
Qi X, Delaney IV W, Ray AS, Yang H, Miller MD, Xiong S. In vitro characterisation of anti-HBV efficacy and intracellular metabolism of tenofovir [Abstract]. J Hepatol 2005;42(Suppl 2):32.
-
(2005)
J Hepatol
, vol.42
, Issue.SUPPL. 2
, pp. 32
-
-
Qi, X.1
Delaney, I.V.W.2
Ray, A.S.3
Yang, H.4
Miller, M.D.5
Xiong, S.6
-
5
-
-
3242694930
-
Tenofovir disoproxil fumarate: Clinical pharmacology and pharmacokinetics
-
Kearney BP, Flaherty JF, Shah J. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clin Pharmacokinet 2004;43:595-612.
-
(2004)
Clin Pharmacokinet
, vol.43
, pp. 595-612
-
-
Kearney, B.P.1
Flaherty, J.F.2
Shah, J.3
-
6
-
-
3242659521
-
Tenofovir primes rhesus macaque cells in vitro for enhanced interleukin-12 secretion
-
Koen KA, Van Rompay KK, Marthas ML, Bischofberger N. Tenofovir primes rhesus macaque cells in vitro for enhanced interleukin-12 secretion. Antiviral Res 2004;63:133-138.
-
(2004)
Antiviral Res
, vol.63
, pp. 133-138
-
-
Koen, K.A.1
Van Rompay, K.K.2
Marthas, M.L.3
Bischofberger, N.4
-
7
-
-
0041379823
-
Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of No-substituted adenines, and 2,6-diaminopurines
-
Zidek Z, Potmesil P, Kmoniekova E, Holy A. Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of No-substituted adenines, and 2,6-diaminopurines. Eur J Pharmacol 2003;475:149-159.
-
(2003)
Eur J Pharmacol
, vol.475
, pp. 149-159
-
-
Zidek, Z.1
Potmesil, P.2
Kmoniekova, E.3
Holy, A.4
-
8
-
-
4644249895
-
Involvement of adenosine A(1) receptors in upregulation of nitric oxide by acyclic nucleotide analogues
-
Zidek Z, Kmoniekova E, Holy A. Involvement of adenosine A(1) receptors in upregulation of nitric oxide by acyclic nucleotide analogues. Eur J Pharmacol 2004;501:79-86.
-
(2004)
Eur J Pharmacol
, vol.501
, pp. 79-86
-
-
Zidek, Z.1
Kmoniekova, E.2
Holy, A.3
-
9
-
-
2542476148
-
Immunopharmacology of CpG oligodeoxynucleotides and ribavirin
-
Vollmer J, Rankin R, Hartmann H, Jurk M, Samulowitz U, Wader T, et al. Immunopharmacology of CpG oligodeoxynucleotides and ribavirin. Antimicrob Agents Chemother 2004;48:2314-2317.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 2314-2317
-
-
Vollmer, J.1
Rankin, R.2
Hartmann, H.3
Jurk, M.4
Samulowitz, U.5
Wader, T.6
-
10
-
-
2142653050
-
Caldwell adenosine receptors and mammalian toll-like receptors: Synergism in macrophages
-
Olah ME, Charles C. Caldwell Adenosine Receptors and Mammalian Toll-Like Receptors: Synergism in Macrophages. Mol Interv 2003;3:370-374.
-
(2003)
Mol Interv
, vol.3
, pp. 370-374
-
-
Olah, M.E.1
Charles, C.2
|